home / stock / nonof / nonof news

NONOF News and Press, Novo-Nordisk A/S From 02/05/24

Stock Information
Company Name: Novo-Nordisk A/S
Stock Symbol: NONOF
Market: OTC
Website: novonordisk.com
Menu
NONOF NONOF Quote NONOF Short NONOF News NONOF Articles NONOF Message Board
Get NONOF Alerts

News, Short Squeeze, Breakout and More Instantly...
NONOF - Eli Lilly Q4 results to highlight Zepbound uptake

2024-02-05 12:38:30 ET More on Eli Lilly Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly sees highest intraday trade since November...
NONOF - AbbVie cites tailwinds to Botox business from weight loss drugs

2024-02-02 13:06:23 ET More on AbbVie AbbVie Q4 Earnings Preview: Few Clouds On Horizon Thanks To Masterful Management (Rating Upgrade) AbbVie Inc. (ABBV) JPMorgan 42nd Annual Healthcare Conference AbbVie: Still Expensive Despite The Great M&A Acumen AbbV...

NONOF - U.S. govt. sends opening bids for drugs selected for Medicare price negotiations

2024-02-01 10:13:39 ET More on Bristol-Myers, Johnson & Johnson, etc. Pfizer Is Down 54% From Highs, Now Yields 6.1% Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Pfizer: Reviewing Q4 Earnings, FY24 Guidance - Why I Disagree Wit...

NONOF - U.S. govt. sends opening bids for drugs selected for Medicare pricing negotiations

2024-02-01 10:13:39 ET More on Bristol-Myers Squibb, Johnson & Johnson, etc. Pfizer Is Down 54% From Highs, Now Yields 6.1% Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Pfizer: Reviewing Q4 Earnings, FY24 Guidance - Why I Disag...
NONOF - Lilly, Novo could be first trillion-dollar health stocks: world's largest sovereign wealth fund

2024-01-31 12:32:57 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Novo Nordisk stock hits all-time high as Wegov...

NONOF - Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript

2024-01-31 11:58:09 ET Novo Nordisk A/S (NVO) Q4 2023 Earnings Conference Call January 31, 2024 07:00 AM ET Company Participants Daniel Bohsen - Head of Investor Relations Lars Fruergaard Jorgensen - President and Chief Executive Officer Camilla Sylvest - Executi...

NONOF - Novo Nordisk GAAP EPS of DKK 4.91, revenue of DKK 65.86B; initiates FY24 outlook

2024-01-31 01:40:15 ET More on Novo Nordisk Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Taking Novo Nordisk To The Next Level Suspected fake Ozempic linked to three cases of low blood sugar in U.S.: Reuters ...
NONOF - Eli Lilly said to be in talks with Germany to win coverage for weight loss drugs

2024-01-29 10:20:11 ET More on Eli Lilly Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly: The Buzz Is Not Over Big Pharma earnings season in spotlight amid positive sentiment Eli Lilly's Mounjaro dose ava...

NONOF - BGY: A Good Way To Diversify Away From American Markets And Earn A High Yield

2024-01-29 05:46:06 ET Summary The BlackRock Enhanced International Dividend Trust is a closed-end fund that offers high current income from foreign stocks. BGY's recent performance has been flat, but when considering distributions, it has delivered a 44.12% total return over the ...

NONOF - Baron International Growth Fund Q4 2023 Shareholder Letter

2024-01-28 20:15:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron International Growth Fund® (the Fund) gained 7.78% (Institutional Shares) d...
Previous 10 Next 10